Mankind Pharma's ANDA220513 for Thiamine Hydrochloride Receives AP Status
Mankind Pharma's application ANDA220513 for Thiamine Hydrochloride has received an Approval Pending (AP) status.
Company
Pharmaceutical intelligence for Mankind Pharma with 14 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.